
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Short-term outcomes of intravitreal faricimab for refractory neovascular age-related macular degeneration
Wissam Al-Jundi, Cristian Munteanu, Berthold Seitz, et al.
Graefe s Archive for Clinical and Experimental Ophthalmology (2024) Vol. 262, Iss. 9, pp. 2867-2874
Closed Access | Times Cited: 5
Wissam Al-Jundi, Cristian Munteanu, Berthold Seitz, et al.
Graefe s Archive for Clinical and Experimental Ophthalmology (2024) Vol. 262, Iss. 9, pp. 2867-2874
Closed Access | Times Cited: 5
Showing 5 citing articles:
Clinical trials and real-world studies examining faricimab and high-dose aflibercept for wet age-related macular degeneration and diabetic macular edema
Meghana Kalavar, Jayanth Sridhar
Current Opinion in Ophthalmology (2025)
Closed Access | Times Cited: 1
Meghana Kalavar, Jayanth Sridhar
Current Opinion in Ophthalmology (2025)
Closed Access | Times Cited: 1
One-Year Real-World Outcomes of Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration
Giuseppe Cancian, A. Paris, Lia Agliati, et al.
Ophthalmology and Therapy (2024) Vol. 13, Iss. 11, pp. 2985-2997
Open Access | Times Cited: 5
Giuseppe Cancian, A. Paris, Lia Agliati, et al.
Ophthalmology and Therapy (2024) Vol. 13, Iss. 11, pp. 2985-2997
Open Access | Times Cited: 5
Real-Life Treatment Intervals and Morphological Outcomes Following the Switch to Faricimab Therapy in Neovascular Age-Related Macular Degeneration
K. B. Low, Vasilena Sitnilska, Yi Tang, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 5, pp. 189-189
Open Access
K. B. Low, Vasilena Sitnilska, Yi Tang, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 5, pp. 189-189
Open Access
Short-Term Comparison of Switching to Brolucizumab or Faricimab from Aflibercept in Neovascular AMD Patients
Akiko Kin, Takahiro Mizukami, Satoru Ueno, et al.
Medicina (2024) Vol. 60, Iss. 7, pp. 1170-1170
Open Access | Times Cited: 1
Akiko Kin, Takahiro Mizukami, Satoru Ueno, et al.
Medicina (2024) Vol. 60, Iss. 7, pp. 1170-1170
Open Access | Times Cited: 1
Real-World Efficacy of Faricimab in Patients with Treatment-Resistant Neovascular Age-Related Macular Degeneration: Outcomes at Six Months
Seung Chul Baek, Areum Jeong, Min Sagong
Journal of Retina (2024) Vol. 9, Iss. 2, pp. 150-155
Open Access
Seung Chul Baek, Areum Jeong, Min Sagong
Journal of Retina (2024) Vol. 9, Iss. 2, pp. 150-155
Open Access